glp-1 pancreatitis Pancreatitis Warnings Strengthened on GLP-1RAs
Description
Image Credit: Visual Capitalist Data: S&P global, GLP-1 Men, Financial times, IFEBP & Reuters #biotech #biopharma #GLP1 #obesity | 14 comments on LinkedIn
The federal government and major drugmakers reach a landmark deal to dramatically cut GLP-1 drug prices, lowering costs for Medicare, Medicaid, and cash-paying patients.
Book Nowand step into a new era of Wellness
Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat
